|
CNOT10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04780000009796E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.39540000005023E-06 |
| Normal-vs-Stage2 |
3.442300E-03 |
| Normal-vs-Stage3 |
1.21950000098181E-08 |
| Normal-vs-Stage4 |
6.09570000031923E-07 |
| Stage1-vs-Stage2 |
9.158600E-01 |
| Stage1-vs-Stage3 |
2.701600E-02 |
| Stage1-vs-Stage4 |
1.312210E-01 |
| Stage2-vs-Stage3 |
1.039650E-01 |
| Stage2-vs-Stage4 |
2.771200E-01 |
| Stage3-vs-Stage4 |
6.566600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.24379999819769E-08 |
| Normal-vs-AfricanAmerican |
3.977800E-03 |
| Normal-vs-Asian |
4.817000E-03 |
| Caucasian-vs-AfricanAmerican |
4.326200E-01 |
| Caucasian-vs-Asian |
8.188000E-02 |
| AfricanAmerican-vs-Asian |
6.298400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10599999994621E-06 |
| Normal-vs-Female |
3.06410000039392E-07 |
| Male-vs-Female |
5.591600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.32259999999318E-05 |
| Normal-vs-Age(41-60Yrs) |
4.61610000224155E-08 |
| Normal-vs-Age(61-80Yrs) |
9.01900000016553E-07 |
| Normal-vs-Age(81-100Yrs) |
4.183300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.154590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.863800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.759200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.078400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.632400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.202800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.632200E-02 |
| Classical-VS-Follicular |
2.992200E-01 |
| Classical-VS-Other |
2.437800E-01 |
| Classical-VS-Normal |
4.1908000000257E-06 |
| Tall-VS-Follicular |
3.425000E-01 |
| Tall-VS-Other |
9.811800E-01 |
| Tall-VS-Normal |
6.23899999996347E-07 |
| Follicular-VS-Other |
6.938200E-01 |
| Follicular-VS-Normal |
1.031170E-04 |
| Other-VS-Normal |
6.242700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.62119999944788E-07 |
| Normal-vs-N1 |
1.03139999985125E-07 |
| N0-vs-N1 |
1.185000E-01 |
|
|
